Aardvark Therapeutics, Inc. (AARD)
3.60
+0.01
(+0.28%)
USD |
NASDAQ |
Jun 09, 16:00
3.60
0.00 (0.00%)
After-Hours: 20:00
Aardvark Therapeutics SG&A Expense (Quarterly) : 5.897M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Alumis, Inc. | 18.61M |
| SIGA Technologies, Inc. | 4.673M |
| ANI Pharmaceuticals, Inc. | 73.66M |
| Corcept Therapeutics, Inc. | 145.36M |
| Assertio Holdings, Inc. | 11.14M |